Selective Anti‐Inflammatory Action of Interleukin‐11 in Murine Lyme Disease: Arthritis Decreases while Carditis Persists
Authors:
Open Access
- 1 March 1999
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 179 (3) , 734-737
Abstract
The role of interleukin (IL)-11, a cytokine with potent anti-inflammatory properties, in murine Lyme disease was investigated. Borrelia burgdorferi—iKeywords
This publication has 11 references indexed in Scilit:
- Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cellsThe Journal of Immunology, 1997
- Ablation of interleukin-12 exacerbates Lyme arthritis in SCID miceInfection and Immunity, 1997
- B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritisInfection and Immunity, 1997
- Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide productionThe Journal of Immunology, 1996
- Effect of anti-interleukin 12 treatment on murine lyme borreliosis.Journal of Clinical Investigation, 1996
- Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in miceThe Journal of Immunology, 1995
- T helper phenotype and genetic susceptibility in experimental Lyme disease.Journal of Experimental Medicine, 1995
- Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirocheteImmunology Letters, 1994
- Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.Journal of Experimental Medicine, 1991
- Lyme Borreliosis in Selected Strains and Ages of Laboratory MiceThe Journal of Infectious Diseases, 1990